6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,3]dioxolo[4,5-b]pyridine, 95.0%, 50mg

Tert-butyl 4-hydroxy-4-(methoxymethyl)piperidine-1-carboxylate, 98%, 5g

Sodium ammonium hydrogen phosphate tetrahydrate, min. 99%, pa, 2.5 kg, plastic packaging.

Sodium butyrate, min. 98%, for synthesis, 25 g, plastic packaging.

2-Ethyl-1h-benzo[d]imidazole-6-carboxylic acid, 95+%, 1g

9-Fluorenecarboxylic Acid>97.0%(T)25g

(3S)-8-fLuoro-1-methyl-3-[2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2,4(1h,3h)-quinazolinedione, 98%, 250mg

N-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-3-(hydroxyamino)-3-iminopropanamide, 97%, 100mg

Lurasidone>98.0%(HPLC)(N)250mg

(5-Propyl-1H-pyrazol-3-yl)methanamine, 95.0%, 5g

Methyl [4,5-dimethoxy-2-(4-trifluoromethyl-phenylsulfamoyl)-phenyl]-acetate, 99.0%, 1g

Patent blue VF (CI 42045), purest, 10 g, glass packaging

2-Amino-3-methylbenzonitrile, 95.0%, 250mg